Due to the unprecedented nature of the COVID-19 pandemic, anyone reporting an Adverse Event and/or a Product Complaint via phone, should you receive a network busy signal (ie: if all lines busy/engaged) please continue to try your call throughout the day. Alternatively, you may email your Adverse Event to email@example.com OR Product Complaint to firstname.lastname@example.org, OR medical information request to MedInfo@propharmagroup.com.
[one_half] Teniposide Injection WG Critical Care provides Teniposide Injection as part of its expanding line of essential injectable products. [fancy_link link=”https://www.wgcriticalcare.com/injectable-pharmaceuticals/our-products/teniposide-injection/” variation=”slategrey”]Please check the product page for more information[/fancy_link] [/one_half] [one_half_last] [image_frame style=”framed” height=”288″ width=”432″]https://www.wgcriticalcare.com/injectable-pharmaceuticals/wp-content/uploads/2013/06/Teniposide-Injection-Carton.jpg[/image_frame] [/one_half_last]Read More
[one_half] Important Product Update: Please order the new NDC, 44567-802-10, 3.375 g in a 30 mL vial. The 3.375 g in a 20 mL vial, NDC 44567-882-10, has now been discontinued at the wholesalers. [fancy_link link=”https://www.wgcriticalcare.com/injectable-pharmaceuticals/our-products/piperacillin-and-tazobactam-for-injection/” variation=”slategrey”]Please check the product page for more information[/fancy_link] [/one_half] [one_half_last][image_frame style=”framed” height=”288″ width=”432″]https://www.wgcriticalcare.com/injectable-pharmaceuticals/wp-content/uploads/2013/07/Piperacillin-and-Tazobactam-For-Injection-3_375g-Post.jpg[/image_frame] [/one_half_last]Read More